TYRA
Tyra Biosciences
$31.06
+$0.43 (+1.4%)Jul 27, 2026
Key metrics
The numbers that frame TYRA today
- Market cap
- $1.85B
- P/E (TTM)
- -14.1
- EV / FCF
- -17.2
- ROIC
- -55.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $9.96
- 52wk High
- $40.65
Growth
Revenue and earnings trend for TYRA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TYRA
Is Tyra Biosciences a good buy?
Hold. Tyra Biosciences has excellent momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Tyra Biosciences is selling at a high price.
What is the market capitalization of TYRA?
Tyra Biosciences's market capitalization is $1.85B.
What is the P/E ratio for TYRA stock?
Tyra Biosciences's current P/E ratio is -14.1.
What is the 52-week high for TYRA stock?
The 52-week high for Tyra Biosciences is $40.65. The current close of $31.06 is 23.6% below that high.
What is the 52-week low for TYRA stock?
The 52-week low for Tyra Biosciences is $9.96. The current close of $31.06 is 211.8% above that low.
Does TYRA stock pay dividends?
Tyra Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TYRA?
Tyra Biosciences's Debt / Equity ratio is 0.02.